[go: up one dir, main page]

FI915381L - SUBSTITUERADE AZOLER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING. - Google Patents

SUBSTITUERADE AZOLER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING. Download PDF

Info

Publication number
FI915381L
FI915381L FI915381A FI915381A FI915381L FI 915381 L FI915381 L FI 915381L FI 915381 A FI915381 A FI 915381A FI 915381 A FI915381 A FI 915381A FI 915381 L FI915381 L FI 915381L
Authority
FI
Finland
Prior art keywords
azoler
substituerade
foerfarande foer
foer framstaellning
och deras
Prior art date
Application number
FI915381A
Other languages
Finnish (fi)
Other versions
FI915381A0 (en
FI915381A7 (en
Inventor
Heinz-Werner Kleemann
Hermann Gerhards
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI915381A0 publication Critical patent/FI915381A0/en
Publication of FI915381A7 publication Critical patent/FI915381A7/en
Publication of FI915381L publication Critical patent/FI915381L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI915381A 1990-11-16 1991-11-14 SUBSTITUERADE AZOLER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING. FI915381L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036645A DE4036645A1 (en) 1990-11-16 1990-11-16 SUBSTITUTED AZOLE, METHOD FOR THE PRODUCTION THEREOF, THE AGENT, AND THEIR USE THEREOF

Publications (3)

Publication Number Publication Date
FI915381A0 FI915381A0 (en) 1991-11-14
FI915381A7 FI915381A7 (en) 1992-05-17
FI915381L true FI915381L (en) 1992-05-17

Family

ID=6418438

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915381A FI915381L (en) 1990-11-16 1991-11-14 SUBSTITUERADE AZOLER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING.

Country Status (17)

Country Link
EP (1) EP0485929A1 (en)
JP (1) JPH04283569A (en)
KR (1) KR920009802A (en)
CN (1) CN1061410A (en)
AU (1) AU8785591A (en)
BR (1) BR9104948A (en)
CA (1) CA2055636A1 (en)
CS (1) CS347091A3 (en)
DE (1) DE4036645A1 (en)
FI (1) FI915381L (en)
HU (1) HUT59673A (en)
IE (1) IE913991A1 (en)
IL (1) IL100058A0 (en)
MX (1) MX9102098A (en)
NO (1) NO914481L (en)
PT (1) PT99521A (en)
ZA (1) ZA919059B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036706A1 (en) * 1990-11-17 1992-05-21 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
DE4309968A1 (en) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives
CA2111662C (en) * 1992-12-17 2004-11-23 Hiroaki Yanagisawa Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
US5300668A (en) * 1993-03-10 1994-04-05 Pfizer Inc. Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates
DE19645313A1 (en) 1996-11-04 1998-05-07 Basf Ag Substituted 3-benzylpyrazoles
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20070182A1 (en) 2005-07-29 2007-03-06 Wyeth Corp CYANOPYRROL-PHENYL AMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS
PE20070404A1 (en) 2005-07-29 2007-05-10 Wyeth Corp COMPOUNDS DERIVED FROM CYANOPYRROL-SULFONAMIDE AS MODULATORS OF THE PROGESTERONE RECEPTOR
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (en) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
JP2016514671A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase agonists and uses thereof
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2023274257A1 (en) * 2021-07-01 2023-01-05 诸葛国琴 Imidazole compound, and intermediate and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86134A (en) * 1987-05-02 1993-06-10 Basf Ag N-substituted azoles, their manufacture and their use as pesticides and compositions containing them
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
CS347091A3 (en) 1992-06-17
KR920009802A (en) 1992-06-25
CN1061410A (en) 1992-05-27
AU8785591A (en) 1992-05-21
JPH04283569A (en) 1992-10-08
IE913991A1 (en) 1992-05-20
NO914481D0 (en) 1991-11-15
BR9104948A (en) 1992-06-23
FI915381A0 (en) 1991-11-14
PT99521A (en) 1992-09-30
DE4036645A1 (en) 1992-05-21
FI915381A7 (en) 1992-05-17
HU913583D0 (en) 1992-01-28
EP0485929A1 (en) 1992-05-20
ZA919059B (en) 1992-07-29
NO914481L (en) 1992-05-18
MX9102098A (en) 1992-07-08
HUT59673A (en) 1992-06-29
IL100058A0 (en) 1992-08-18
CA2055636A1 (en) 1992-05-17

Similar Documents

Publication Publication Date Title
FI913917A7 (en) 3-AMIDOPYRAZOLDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH FARMACEUTISKA KOMPOSITIONER INNEHAOLLANDE DESSA.
FI916025A7 (en) DOSERINGS- OCH SPRAYPUMP FOER MATNING AV FLYTANDE, LAOGVISKOESA OCH PASTAFORMIGA AEMNEN.
FI912615A7 (en) FOERFARANDE OCH ANORDNING FOER KONTINUERLIG TORKNING AV TRAESPAON, TRAEFIBRER OCH ANNAT LOESGODS.
FI911936A7 (en) BENZIMIDAZOLDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING.
FI913703L (en) HYDRERINGSKATALYSATORKOMPOSITION, FRAMSTAELLNING OCH ANVAENDNING AV DENNA.
FI911211L (en) ROMBOEDRISKT KALCIUMKARBONAT OCH ACCELERERAT, TERMISKT AOLDRINGSFOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI912379L (en) ELDFAST, VATTENBESTAENDIGT OCH SYRAFAST BINDEMEDEL.
FI913503A7 (en) BENSIMIDAZOLER, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI911584L (en) SUBSTITUERADE AZOLER, FOERFARANDE FOER DERAS FRAMSTAELLNING, DESSA INNEHAOLLANDE AEMNEN OCH DERAS ANVAENDNING.
FI910751A7 (en) SMOERJMEDEL, TILLSATSAEMNEN AV SMOERJMEDEL OCH SMOERJNINGSFOERFARANDEN FOER OLJEBASSMORDA ALKOHOLFOERBRUKANDE SPRUTFOERBRAENNINGSMOTORER.
FI910311A0 (en) KALORIFATTIGA, ICKE-KARIOGENA AETBARA KOMPOSITIONER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING.
FI914275L (en) BENZIMIDAZOLDERIVAT, FRAMSTAELLNING OCH ANVAENDNING AV DESSA.
FI915381L (en) SUBSTITUERADE AZOLER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH DERAS ANVAENDNING.
FI910440A7 (en) ALKENYLGRUPPER INNEHAOLLANDE SILOXANKOPOLYMERER, DERAS FRAMSTAELLNING OCH ANVAENDNING.
FI910368L (en) FOERFARANDE FOER FRAMSTAELLNING AV TRAEKOMPOSITIONSKIVOR, FOERPRESSTAETNINGSKOMPOSITIONER OCH ANVAENDNING AV DESAMMA.
FI914182A0 (en) MAETNINGSFOERFARANDE FOER MAGNETFAELT, MAETNINGSAPPARAT FOER MAGNETFAELT, VISNINGSFOERFARANDE FOER MAGNETFAELT OCH VISNINGSAPPARAT FOER MAGNETFAELT.
FI910032L (en) MIKROFIBRER BESTAOENDE AV SYNDIOTAKTISKA VINYLAROMATICSKA POLYMERER, MIKROFIBERMATTOR OCH SMAELTBLAOSNINGSPROCESS FOER FRAMSTAELLNING AV DESSA.
FI912223L (en) KATALYTKOMPOSITIONER OCH POLYMERISERINGSFOERFARANDE, HEXAKISPHOSFINER OCH HEXAHALOGENFOERENINGAR.
FI914776L (en) INHIBITORER FOER BILDNING AV TUMOERNEKROSFAKTOR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH ANVAENDNING DAERAV.
FI903951A7 (en) FOERFARANDE FRAMSTAELLNING, OCH ANORDNING FOER FOERVERKLIGANDE AV FOERFARANDE.
FI914114L (en) JODINERADE, ICKE-JONISERADE FOERENINGAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE KONTRASTMEDEL.
FI911603A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV 2 -DEOXI-D-TREOPENTOFURANOSIDER, MELLANPRODUKTER FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING.
FI902611A0 (en) ARKIVLAODA FOER LOESA DOKUMENT, MAGASIN OCH PROSYRER.
FI911084A0 (en) 5-PHENYL-1H-PYRAZOLE-4-PROPIONSYRADERIVATOR, FRAMSTAELLNING OCH ANVAENDNING AV DESAMMA.
FI904542A7 (en) KOPPLINGSFOTSYSTEM FOER YTFOGNINGSKOMPONENTER, YTFOGNINGSKOMPONENT OCH MONTERINGSFOERFARANDE FOER DESSA.